Harrington KJ - Search Results

1

Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model.

Harrington KJ, Rowlinson-Busza G, Syrigos KN, Vile RG, Uster PS, Peters AM, Stewart JS. Harrington KJ, et al. Clin Cancer Res. 2000 Dec;6(12):4939-49. Clin Cancer Res. 2000. PMID: 11156255

2

Surgical clips in planning the electron boost in breast cancer: a qualitative and quantitative evaluation.

Harrington KJ, Harrison M, Bayle P, Evans K, Dunn PA, Lambert HE, Saidan Z, Lynn J, Stewart JS. Harrington KJ, et al. Int J Radiat Oncol Biol Phys. 1996 Feb 1;34(3):579-84. doi: 10.1016/0360-3016(95)02090-x. Int J Radiat Oncol Biol Phys. 1996. PMID: 8621281 Clinical Trial.

3

Cancer-related thromboembolic disease in patients with solid tumours: a retrospective analysis.

Harrington KJ, Bateman AR, Syrigos KN, Rintoul R, Bhidayasiri R, McCormack M, Thomas H. Harrington KJ, et al. Ann Oncol. 1997 Jul;8(7):669-73. doi: 10.1023/a:1008230706660. Ann Oncol. 1997. PMID: 9296220 Free article.

4

Response and cosmetic outcome of two fractionation regimens for AIDS-related Kaposi's sarcoma.

Harrison M, Harrington KJ, Tomlinson DR, Stewart JS. Harrison M, et al. Among authors: harrington kj. Radiother Oncol. 1998 Jan;46(1):23-8. doi: 10.1016/s0167-8140(97)00141-2. Radiother Oncol. 1998. PMID: 9488123 Clinical Trial.

5

Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer.

Syrigos KN, Harrington K, Waxman J, Krausz T, Pignatelli M. Syrigos KN, et al. J Urol. 1998 Nov;160(5):1889-93. J Urol. 1998. PMID: 9783980

6

Role of adhesion molecules in bladder cancer: an important part of the jigsaw.

Syrigos KN, Harrington KJ, Pignatelli M. Syrigos KN, et al. Among authors: harrington kj. Urology. 1999 Feb;53(2):428-34. doi: 10.1016/s0090-4295(98)00527-5. Urology. 1999. PMID: 9933073

7

Abnormal expression of p120 correlates with poor survival in patients with bladder cancer.

Syrigos KN, Karayiannakis A, Syrigou EI, Harrington K, Pignatelli M. Syrigos KN, et al. Eur J Cancer. 1998 Dec;34(13):2037-40. doi: 10.1016/s0959-8049(98)00279-2. Eur J Cancer. 1998. PMID: 10070307

8

Liposomes as vehicles for targeted therapy of cancer. Part 1: preclinical development.

Harrington KJ, Lewanski CR, Stewart JS. Harrington KJ, et al. Clin Oncol (R Coll Radiol). 2000;12(1):2-15. doi: 10.1053/clon.2000.9104. Clin Oncol (R Coll Radiol). 2000. PMID: 10749014 Review. No abstract available.

9

Liposomes as vehicles for targeted therapy of cancer. Part 2: clinical development.

Harrington KJ, Lewanski CR, Stewart JS. Harrington KJ, et al. Clin Oncol (R Coll Radiol). 2000;12(1):16-24. doi: 10.1053/clon.2000.9105. Clin Oncol (R Coll Radiol). 2000. PMID: 10749015 Review. No abstract available.

10

Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery.

Harrington KJ, Rowlinson-Busza G, Syrigos KN, Uster PS, Vile RG, Stewart JS. Harrington KJ, et al. Clin Cancer Res. 2000 Jun;6(6):2528-37. Clin Cancer Res. 2000. PMID: 10873109

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters